Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPOH-HD-2002: Optimization of Chemotherapy for Pediatric Hodgkin's Lymphoma
NCT00416832Phase 2Completed
- Start
- Nov 2002
- Primary completion
- Dec 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dacarbazine, etoposide in Hodgkin lymphoma (HL). Started Nov 2002; status: completed.
02
Drugs
dacarbazineetoposide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00416832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416832.